Renal oxygenation defects in the spontaneously hypertensive rat: Role of AT1 receptors

Kidney International

Volumn 63, Issue 1, 2003, Pages 202-208

  Welch, William J ^a,b   Baumgärtl, Horst ^a,b   Lübbers, Dietrich ^a,b   Wilcox, Christopher S ^a,b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Angiotensin receptor blocker (ARB); Candesartan; Hypertension; Nitric oxide; Oxidative stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; RESERPINE; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY FUNCTION; MALE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT; TISSUE OXYGENATION;

EID: 0037213490     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00729.x     Document Type: Article

References (37)

1. Kiil F: Renal energy metabolism and regulation of sodium reabsorption. Kidney Int 11:153-160, 1977
2. Lassen UV, Thaysen JH: Correlation between sodium transport and oxygen consumption in isolated renal tissue. Biochim Biophys Acta 47:610-618, 1961
3. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59:230-237, 2001
4. 2 uptake in days during hypoxia and hydrochlorothiazide infusion. Proc Soc Exp Biol Med 106:714-717, 1961
5. Laycock SK, Vogel T, Forfia PR, et al: Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82:1263-1271, 1998
6. Wolin MS, Xie YW, Hintze TH: Nitric oxide as a regulator of tissue oxygen consumption. Curr Opin Nephrol Hypertens 8:97-103, 1999
7. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1411:217-230, 1999
8. Welch WJ, Tojo A, Wilcox CS: Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol 278:F769-F776, 2000
9. 1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59:1257-1263, 2001
10. Welch WJ, Wilcox CS: Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 89:1857-1865, 1992
11. Schurek HJ, Jost U, Baumgärtl H, et al: Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol 259:F910-F915, 1990
12. Lübbers DW: Oxygen electrodes and optodes and their application in vivo (chapt 2), in Oxygen Transport to Tissue (vol XVII), edited by Ince P et al, New York, Plenum Press, 1996, pp 13-34
13. 2 pressure in the cellular range of living tissue: Its construction and properties, in Polarographic Oxygen Sensors, edited by Gnaiger, Forstner H, Berlin, Springer-Verlag, 1983, pp 37-65
14. Baylis C, Harvey J, Engels K: Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J Am Soc Nephrol 5:211-214, 1994
15. Schurek HJ, Jost U, Bertram H, et al: Preglomerular cortical oxygen diffusion shunt: A prerequisite for effective erythropoietin regulation? Contrib Nephrol 76:57-66, 1989
16. Gullans SR, Hebert SC: Metabolic basis of ion transport, in The Kidney, edited by Brenner BM, Philadelphia, W.B. Saunders, Inc, 2000
17. Klahr S, Hammerman M: Renal metabolism, in The Kidney: Physiology and Pathophysiology, edited by Seldin DW, Giebisch G, New York, Raven Press, 1985, pp 699-718
18. +-resorbtion. Arch Ges Physiol 273:636-650, 1961
19. Knox FG, Flemming JS, Rennie DW: Effect of osmotic diuresis on sodium reabsorption and oxygen consumption of kidney. Am J Physiol 219:751-759, 1966
20. Meyer TN, Schwesinger C, Ye J, et al: Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem 276:22048-22055, 2001
21. Brazy PC, Klotman PE: Increased oxidative metabolism in renal tubules from spontaneously hypertensive rats. Am J Physiol 257: F818-F825, 1989
22. +)-ATPase: Inactivation and degradation induced by oxygen radicals. Int J Biochem 24:621-626, 1992
23. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274:19323-19328, 1999
24. Welch WJ, Tojo A, Lee J-U, et al: Nitric oxide synthase in the JGA of the SHR: Expression and role in tubuloglomerular feedback. Am J Physiol 277:F130-F138, 1999
25. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32:59-64, 1998
26. Chabrashvili T, Tojo A, Onozato ML, et al: Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39:269-274, 2002
27. Gossmann J, Thurmann P, Bachmann T, et al: Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. Kidney Int 50:973-978, 1996
28. Julian BA, Brantley RR Jr, Barker CV, et al: Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol 9:1104-1108, 1998
29. Plata R, Cornejo A, Arratia C, et al: Angiotensin-converting enzyme inhibition therapy in altitude polycythaemia: A prospective randomised trial. Lancet 359:663-666, 2002
30. Gossmann J, Burkhardt R, Harder S, et al: Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60:83-86, 2001
31. Fyhrquist F, Karppinen K, Honkanen T, et al: High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Intern Med 226:257-260, 1989
32. Azizi M, Rousseau A, Ezan E, et al: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 97:839-844, 1996
33. Azizi M, Ezan E, Reny J-L, et al: Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans. Hypertension 33:879-886, 1999
34. Koury ST, Bondurant MC, Koury MJ: Localization of erythro-poietin synthesizing cells in murine kidneys by in situ hybridization. Blood 71:524-527, 1988
35. Shih S-C, Claffey KP: Hypoxia-mediated regulation of gene expression in mammalian cells. Int J Exp Pathol 79:347-357, 2000
36. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW: Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201:1153-1162, 2000
37. Zhu H, Bunn HF: Oxygen sensing and signaling: Impact on the regulation of physiologically important genes. Resp Physiol 115:239-247, 1999